Insulin detemir in routine clinical practice: a 26-week follow-up in type 1 diabetic patients from the Belgian PREDICTIVE Cohort.

@article{Preumont2009InsulinDI,
  title={Insulin detemir in routine clinical practice: a 26-week follow-up in type 1 diabetic patients from the Belgian PREDICTIVE Cohort.},
  author={Vanessa Preumont and Martin Buysschaert and Sophie De Beukelaer and Chantal Mathieu},
  journal={Acta clinica Belgica},
  year={2009},
  volume={64 1},
  pages={49-55}
}
AIM PREDICTIVE (Predictable Results and Experience in Diabetes Through Intensification and Control to Target: an International Variability Evaluation) is a multi-national study designed to evaluate the safety and efficacy of insulin detemir (Levemir) in "real world" medical practice. The aim of the study is to report the PREDICTIVE results of the Belgian type 1 diabetic cohort. METHODS Two hundred and thirty-two patients treated with a basal-bolus insulin scheme were considered for analysis… CONTINUE READING